REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 31st October 2024 |
for |
Steven Gill Anaesthetic Services Ltd |
REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 31st October 2024 |
for |
Steven Gill Anaesthetic Services Ltd |
Steven Gill Anaesthetic Services Ltd (Registered number: 07394815) |
Contents of the Financial Statements |
for the Year Ended 31st October 2024 |
Page |
Balance Sheet | 1 |
Notes to the Financial Statements | 2 |
Steven Gill Anaesthetic Services Ltd (Registered number: 07394815) |
Balance Sheet |
31st October 2024 |
31.10.24 | 31.10.23 |
Notes | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
PROVISIONS FOR LIABILITIES |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 7 |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |
Steven Gill Anaesthetic Services Ltd (Registered number: 07394815) |
Notes to the Financial Statements |
for the Year Ended 31st October 2024 |
1. | COMPANY INFORMATION |
Steven Gill Anaesthetic Services Ltd is a |
Registered number: |
Registered office: |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Revenue from the provision of professional services is recognised on delivery of the service. |
Tangible fixed assets |
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss. |
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis: |
Computer equipment - 25% on cost |
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Steven Gill Anaesthetic Services Ltd (Registered number: 07394815) |
Notes to the Financial Statements - continued |
for the Year Ended 31st October 2024 |
2. | ACCOUNTING POLICIES - continued |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
Research and development expenditure |
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | TANGIBLE FIXED ASSETS |
Motor | Computer |
vehicles | equipment | Totals |
£ | £ | £ |
COST |
At 1st November 2023 |
Additions |
At 31st October 2024 |
DEPRECIATION |
At 1st November 2023 |
Charge for year |
At 31st October 2024 |
NET BOOK VALUE |
At 31st October 2024 |
At 31st October 2023 |
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.10.24 | 31.10.23 |
£ | £ |
Trade debtors |
Other debtors |
Included in debtors is a loan of £140,933.23 (2023: £121,113) to a company, Safe IV Ltd, of which the director is sole director and shareholder. All transactions were at arms length. |
The loan relates to costs incurred in respect of patent applications and development costs of a medical device designed by the director and previously held as prepayments, until they could be capitalized once the patent was granted. |
The patent attorneys engaged in respect of the patent applications, advised the director that it would be beneficial if these costs were kept separately from his trading income and a new company was incorporated for this purpose. |
The loan will not be repaid until Safe IV Ltd is earning income form either the device or the sale of patents. No interest is currently charged on this loan. |
Steven Gill Anaesthetic Services Ltd (Registered number: 07394815) |
Notes to the Financial Statements - continued |
for the Year Ended 31st October 2024 |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.10.24 | 31.10.23 |
£ | £ |
Corporation tax payable |
Social security and other taxes |
Directors' current accounts | 5,273 | 1,082 |
Accrued expenses |
7. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.10.24 | 31.10.23 |
value: | £ | £ |
Ordinary A | £1 | 60 | 60 |
Ordinary B | £1 | 40 | 40 |
100 | 100 |
The Ordinary A shares confer on the holder the right to vote upon any resolution proposed at any general meeting of the company. |
The Ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company. |
The Ordinary A and Ordinary B shares rank pari passu in respect of dividend and capital distribution rights. |
8. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following advances and credits to a director subsisted during the years ended 31st October 2024 and 31st October 2023: |
31.10.24 | 31.10.23 |
£ | £ |
Balance outstanding at start of year | ( |
) | ( |
) |
Amounts advanced |
Amounts repaid | ( |
) | ( |
) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of year | ( |
) | ( |
) |
The loan is repayable on demand and no interest was charged during the year. |
9. | CONTROL |
The ultimate controlling party is Dr S P Gill by virtue of holding 100% of the voting share capital. |